AI-Platform to Tackle Cancer on a Genetic Level

November 22, 2024

We’re building an AI-powered platform to tackle cancer on a genetic level.

What does the platform do?

1. Performs analyse of a person’s genetic code.

2. Identifies mutations in the genetic code.

3. Explores ways to suppress these gene mutations.

The process is powered by AI. Our data is based on renowned publications and is updated daily.

Through this process, we can understand which mutations lead to specific diseases and, accordingly, identify which medications or off-label drugs could help suppress the mutation, enabling the person to recover.

This platform, based on our profound expertise in the field of oncology backed up by AI, is an innovative way to address the problem at its root.

Targeting Extracellular Vesicles 2025 congress in Valencia

🧬 Exploring the Future of Extracellular Vesicle Science This month, we attended the Targeting Extracellular Vesicles

Hello Ilmac Basel 2025

We were delighted to attend Ilmac Basel 2025 again! This year’s focus on AI & digital

New ISO Certification

🏆 We’re proud to share that Vita Motus AG has once again been awarded the ISO